Searched for
BIONTECH SE
GSK set to get $500 million from settlement of mRNA lawsuitCureVac NV has settled its US patent dispute with Pfizer and BioNTech SE regarding mRNA vaccines, resulting in GSK receiving up to $500 mil...- Germany’s BioNTech revises plans for African vaccine factory networkIn a potential blow for Africa’s hopes of greater vaccine self-reliance, the German biotech company is currently not moving forward with a ...
- Moderna open to supplying COVID vaccines to China, CEO says"We are open, we have the capacity" Bancel said about supplying its mRNA-based shots to the country, declining to say whether Moderna had s...
- Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccineModerna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...
- Pfizer vaccine for children under five may be available in U.S. by end of FebruaryThe report says that the FDA urged the companies to submit the application so that regulators could begin reviewing the two-shot data.
- Pfizer to test third dose of COVID-19 vaccine in childrenThe study will now include a third dose of 3 microgram given at least two months after the second dose of the two-dose series to provide hi...
- BioNTech starts work on Omicron-specific vaccineOver the weekend, the list of countries that have spotted the new variant in travelers grew. Portugal detected 13 cases linked to the new v...
- U.S. COVID-19 booster rollout to initially proceed with just Pfizer vaccine: SourcesModerna Inc's booster submission was found inadequate and the U.S. Food and Drug Administration requires stronger data from the company, ma...
- BioNTech shot produces 10x more antibodies than Sinovac: StudyThe research, published in The Lancet, found that antibody levels among Hong Kong health workers who have been fully vaccinated with BioNTe...
- Taiwan's Terry Gou, TSMC reach initial agreements for BioNTech vaccinesTaiwan's government has tried for months to buy the shots directly from Germany's BioNTech and has blamed China, which claims the self-rule...
- Taiwan says China blocked deal with BioNTech for COVID-19 shotsTaiwan has millions of vaccine doses on order, from AstraZeneca Plc and Moderna Inc, but has received only slightly more than 700,000 to da...
- Pfizer to develop new vaccines on its own using mRNA technologyThe drugmaker said it was ready to pursue mRNA on its own following its experience in the past year working on the COVID-19 vaccine, the WS...
- Pfizer/BioNTech say COVID-19 vaccine likely to prevent asymptomatic infectionThe companies also said the latest analysis of the Israeli data shows the vaccine was 97% effective in preventing symptomatic disease, seve...
- Pfizer Covid shot neutralises Brazilian strain in lab studyIn lab experiments, the shot demonstrated “roughly equivalent” levels of neutralising activity against the Brazil and UK strains compared w...
- Fosun Pharma to buy 100 million doses of BioNTech's COVID-19 vaccine for mainland ChinaFosun said it will be entitled to 60% of annual gross profit from sales of doses that it will make from imported bulk ingredients, and 65% ...
- With US now in hand, Germany's BioNTech CEO looks for more vaccine production"The baseline plan is 1.3 billion doses," Sahin said. "And we are working on an extended plan. I can't tell you at the moment what is possi...
- Pfizer not yet ready to release COVID-19 vaccine data from late-stage trialPharma major Pfizer Inc said the company could release data on whether or not the vaccine works as early as this month.
- U.S. to pay Pfizer and BioNTech $1.95 billion to produce millions of doses of COVID-19 vaccinePfizer will deliver the doses if the product receives Emergency Use Authorization or licensure from the U.S. Food and Drug Administration, ...
- Pfizer, BioNTech's COVID-19 vaccine expected to be ready for approval by year endThe experimental vaccine, which showed promise against the fast-spreading respiratory illness in early stage human testing, is expected to ...
- Pfizer, BioNTech to co-develop potential coronavirus vaccineThe drugmakers will start the collaboration immediately and have signed a letter of intent for the vaccine's distribution outside China, th...
Load More
